Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Phase 1 | China | 28 Sep 2022 | |
| Glioma | Preclinical | China | 06 Jul 2023 |





